200 related articles for article (PubMed ID: 19203999)
1. Calcineurin activates cytoglobin transcription in hypoxic myocytes.
Singh S; Manda SM; Sikder D; Birrer MJ; Rothermel BA; Garry DJ; Mammen PP
J Biol Chem; 2009 Apr; 284(16):10409-21. PubMed ID: 19203999
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN
J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
6. Interspecies comparison of neuroglobin, cytoglobin and myoglobin: sequence evolution and candidate regulatory elements.
Wystub S; Ebner B; Fuchs C; Weich B; Burmester T; Hankeln T
Cytogenet Genome Res; 2004; 105(1):65-78. PubMed ID: 15218260
[TBL] [Abstract][Full Text] [Related]
7. Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo.
Oka T; Dai YS; Molkentin JD
Mol Cell Biol; 2005 Aug; 25(15):6649-59. PubMed ID: 16024800
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling.
Sato-Matsubara M; Matsubara T; Daikoku A; Okina Y; Longato L; Rombouts K; Thuy LTT; Adachi J; Tomonaga T; Ikeda K; Yoshizato K; Pinzani M; Kawada N
J Biol Chem; 2017 Nov; 292(46):18961-18972. PubMed ID: 28916723
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
Langfermann DS; Rössler OG; Thiel G
Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
[TBL] [Abstract][Full Text] [Related]
11. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
12. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.
Lim HW; New L; Han J; Molkentin JD
J Biol Chem; 2001 May; 276(19):15913-9. PubMed ID: 11279073
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
16. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
17. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
Muckenfuss H; Hamdorf M; Avots A; Sanzenbacher R; Tschulena U; Cichutek K; Flory E
Mol Immunol; 2006 Mar; 43(8):1172-82. PubMed ID: 16125242
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1.
Santalucía T; Christmann M; Yacoub MH; Brand NJ
Cardiovasc Res; 2003 Sep; 59(3):639-48. PubMed ID: 14499865
[TBL] [Abstract][Full Text] [Related]
19. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.
Liu Q; Wilkins BJ; Lee YJ; Ichijo H; Molkentin JD
Mol Cell Biol; 2006 May; 26(10):3785-97. PubMed ID: 16648474
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle.
Alfieri CM; Evans-Anderson HJ; Yutzey KE
Am J Physiol Cell Physiol; 2007 May; 292(5):C1887-94. PubMed ID: 17229811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
